Management of Hypertension in Patients With Diabetes Using an Amlodipine-, Olmesartan Medoxomil-, and Hydrochlorothiazide-Based Titration Regimen
Author:
Funder
Daiichi-Sankyo
Publisher
Elsevier BV
Subject
Cardiology and Cardiovascular Medicine
Reference14 articles.
1. Efficacy of amlodipine and olmesartan medoxomil in patients with hypertension: the AZOR Trial Evaluating Blood Pressure Reductions and Control (AZTEC) study;Punzi;Ther Adv Cardiovasc Dis,2010
2. Blood pressure surge on increasing;Gosse;J Hypertens,2004
3. Morning surge in blood pressure as a predictor of silent and clinical cerebrovascular disease in elderly hypertensives: a prospective study;Kario;Circulation,2003
4. Circadian variation and triggers of onset of acute cardiovascular disease;Muller;Circulation,1989
5. Recommendations for blood pressure measurement in humans and experimental animals;Pickering;Circulation,2005
Cited by 23 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Efficacy of combined antihypertensive therapy in patients with type 2 diabetes mellitus and non-alcoholic fatty liver disease with various polymorphisms of the CYP2C9 gene;Systemic Hypertension;2024-06-26
2. Real-World Effectiveness and Safety of a Single-Pill Combination of Olmesartan/Amlodipine/Hydrochlorothiazide in Korean Patients with Hypertension and Cardiovascular Risk Factors;Advances in Therapy;2023-08-31
3. Single-Pill Combination with Three Antihypertensive Agents to Improve Blood Pressure Control in Hypertension: Focus on Olmesartan-Based Combinations;High Blood Pressure & Cardiovascular Prevention;2023-01-25
4. Clinical Efficacy and Safety of Combination Therapy with Amlodipine and Olmesartan or an Olmesartan/Hydrochlorothiazide Compound for Hypertension: A Prospective, Open-Label, and Multicenter Clinical Trial in China;Current Therapeutic Research;2019
5. OLMESARTAN MEDOXOMIL-LOADED SELF-NANOEMULSIFYING DRUG DELIVERY SYSTEMS: DESIGN, &ITIN&IT-&ITVITRO &ITCHARACTERIZATION, AND PHARMACOKINETIC ASSESSMENTS IN RABBITS &ITVIA &ITLC - MS/MS;International Journal of Pharmaceutical Sciences and Research;2018-03-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3